Morepen Laboratories is strengthening its position in the global Active Pharmaceutical Ingredients (API) market while expanding into the Contract Development and Manufacturing Organisation (CDMO) segment, according to Managing Director Sanjay Suri. In his message to shareholders in the company’s Annual Report 2026, Suri said Morepen continues to focus on manufacturing high-quality APIs for diverse geographies […]